Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2018-12-14 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
独立董事关于第四届董事会第十六次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors of Guangzhou Yangpu Medical Technology Co., Ltd. regarding matters discussed at the 16th meeting of the 4th board of directors. It includes opinions on a debt-to-equity investment by a wholly-owned subsidiary and amendments to the company's articles of association. The document references compliance with relevant laws and regulations and confirms the legality and fairness of the transactions and amendments. There is no financial data, earnings information, or report publication announcement. The content is focused on board-level opinions and governance matters related to board decisions and company bylaws. Therefore, this document fits best under Board/Management Information (MANG), which covers announcements of changes or opinions related to the company's board or senior management activities.
2018-12-14 Chinese
第四届董事会第十六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 16th meeting of the 4th Board of Directors of Guangzhou Yangpu Medical Technology Co., Ltd. It details decisions such as capital increase in a subsidiary, external investment by a subsidiary, and amendments to the company bylaws. It includes voting results and mentions that some matters will be submitted to the shareholders' meeting later. The content focuses on board meeting decisions and governance matters rather than financial results, audit opinions, or regulatory filings. The document length is short (1567 characters) and it is not a report itself but a meeting resolution announcement. Therefore, it fits best under Board/Management Information (MANG).
2018-12-14 Chinese
关于全资子公司对外投资的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding an external investment by its wholly-owned subsidiary. It details the investment structure, the parties involved, financial data of the target company, transaction terms, risks, and impact on the company. The document is a formal disclosure about a capital investment transaction (debt-to-equity swap) and does not contain financial statements or comprehensive financial performance data. It is not an annual or interim report, nor an earnings release. It is not a regulatory certification or a report publication announcement. The content fits best with a Capital/Financing Update as it informs about a financing-related transaction and capital structure change involving a subsidiary's investment in another company. The document length is about 4107 characters, which is consistent with an announcement rather than a full report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2018-12-14 Chinese
公司章程修正案
Governance Information Classification · 95% confidence The document is titled '章程修正案' which translates to 'Articles of Association Amendment' or 'Amendment to the Company Bylaws'. It details specific changes to the company's articles of association, including provisions about share repurchases, board powers, and other governance-related clauses. The document is dated December 14, 2018, and is issued by the company's board of directors. There is no financial data, earnings information, or audit content. Instead, it focuses on governance structure and internal company rules. This fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is 3202 characters, which is sufficient for a detailed governance amendment but too short for a full annual or interim report. Therefore, the appropriate classification is CGR with high confidence.
2018-12-14 Chinese
第四届监事会第十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Guangzhou Yangpu Medical Technology Co., Ltd. It details decisions made during the 10th meeting of the 4th Supervisory Board, including capital increase for a subsidiary, external investment by a subsidiary, and amendments to the company's articles of association. The document includes voting results and references to related announcements on the stock exchange disclosure platform. It does not contain financial statements or detailed financial data but rather reports on board-level decisions and approvals. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the company's board or senior management bodies.
2018-12-14 Chinese
关于持股5%以上股东股份质押延期购回的公告
Capital/Financing Update Classification · 100% confidence The document is a public announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding the extension of the repurchase period for pledged shares held by a shareholder owning more than 5% of the company's shares. It details the shareholder's pledge and extension dates, the number of shares involved, and related pledge and freeze information. The content focuses on share pledge and repurchase extension, which is a capital structure or financing activity update. The document length is short (1162 characters), and it is not a full financial report or earnings release. Therefore, it fits best under Capital/Financing Update (CAP).
2018-12-12 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.